A recellularized human colon model identifies cancer driver genes

Nature Biotechnology

Volumn 34, Issue 8, 2016, Pages 845-851

  Chen, Huanhuan Joyce ^a   Wei, Zhubo ^b   Sun, Jian ^c   Bhattacharya, Asmita ^d   Savage, David J ^e   Serda, Rita ^e   Mackeyev, Yuri ^f   Curley, Steven A ^g   Bu, Pengcheng ^a   Wang, Lihua ^h   Chen, Shuibing ^c   Cohen Gould, Leona ^c   Huang, Emina ⁱ   Shen, Xiling ^a   Lipkin, Steven M ^c   Copeland, Neal G ^b   Jenkins, Nancy A ^b   Shuler, Michael L ^a  

^a School of Operations Research and Industrial Engineering   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d University of Texas Medical School at Houston ^*  (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f RICE UNIVERSITY   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h Department of Biological and Environmental Engineering   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; DISEASES; GENES; MUTAGENESIS;

CANCER BIOLOGY; CANCER MODELS; CLINICAL RESEARCH; COLORECTAL CANCER; INVASIVE TUMORS; PATHOPHYSIOLOGICAL; RECELLULARIZATION; SLEEPING BEAUTY TRANSPOSON;

CELL ENGINEERING;

EPHRIN RECEPTOR B1; EPHRIN RECEPTOR B2; PROTEIN MSH2; TRANSCRIPTION FACTOR 7 LIKE 2; APC PROTEIN; APC PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CANCER GROWTH; CANCER MODEL; CAPILLARY ENDOTHELIAL CELL; COLON; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EPHB1 GENE; EPHB2 GENE; EX VIVO STUDY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MSH2 GENE; MUTAGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SLEEPING BEAUTY TRANSPOSON MUTAGENESIS; TCF7L2 GENE; TRANSPOSON; TUMOR GENE; TUMOR SUPPRESSOR GENE; TWIST2 GENE; CARCINOGENESIS; CELL CULTURE; CELL FREE SYSTEM; COLON TUMOR; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; ORGANOGENESIS; PATHOLOGY; PROCEDURES; TISSUE ENGINEERING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; CARCINOGENESIS; CELL-FREE SYSTEM; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HUMANS; NEOPLASM PROTEINS; ORGANOGENESIS; TISSUE ENGINEERING;

EID: 84981349638     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3586     Document Type: Article

References (49)

1. Arrowsmith, J. Trial watch: Phase II failures: 2008-2010. Nat. Rev. Drug Discov. 10, 328-329 (2011).
2. Gout, S. & Huot, J. Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron. 1, 69-83 (2008).
3. Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107, 18545-18550 (2010).
4. Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. USA 105, 4283-4288 (2008).
5. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
6. Copeland, N.G. & Jenkins, N.A. Deciphering the genetic landscape of cancer-from genes to pathways. Trends Genet. 25, 455-462 (2009).
7. Li, X. et al. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat. Med. 20, 769-777 (2014).
8. Matano, M. et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21, 256-262 (2015).
9. Jung, P. et al. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 17, 1225-1227 (2011).
10. Gilbert, T.W., Sellaro, T.L. & Badylak, S.F. Decellularization of tissues and organs. Biomaterials 27, 3675-3683 (2006).
11. Ott, H.C. et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 16, 927-933 (2010).
12. Ott, H.C. et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213-221 (2008).
13. Ridky, T.W., Chow, J.M., Wong, D.J. & Khavari, P.A. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nat. Med. 16, 1450-1455 (2010).
14. G12D stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387 (2004).
15. Biswas, S. et al. Transforming growth factor-β receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res. 64, 4687-4692 (2004).
16. Trobridge, P. et al. TGF-β receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a β-catenin-independent pathway. Gastroenterology 136, 1680-1688.e7 (2009).
17. Lohi, J. et al. Laminins, tenascin and type VII collagen in colorectal mucosa. Histochem. J. 28, 431-440 (1996).
18. Vermeulen, L. et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 105, 13427-13432 (2008).
19. Liotta, L.A. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am. J. Pathol. 117, 339-348 (1984).
20. Lau, W., Barker, N. & Clevers, H. WNT signaling in the normal intestine and colorectal cancer. Front. Biosci. 12, 471-491 (2007).
21. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
22. Wood, L.D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007).
23. Oshima, H. et al. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer. Cancer Res. 75, 766-776 (2015).
24. Copeland, N.G. & Jenkins, N.A. Harnessing transposons for cancer gene discovery. Nat. Rev. Cancer 10, 696-706 (2010).
25. Dupuy, A.J., Akagi, K., Largaespada, D.A., Copeland, N.G. & Jenkins, N.A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436, 221-226 (2005).
26. March, H.N. et al. Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat. Genet. 43, 1202-1209 (2011).
27. Takeda, H. et al. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression. Nat. Genet. 47, 142-150 (2015).
28. Grabundzija, I. et al. Comparative analysis of transposable element vector systems in human cells. Mol. Ther. 18, 1200-1209 (2010).
29. Brett, B.T. et al. Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PLoS One 6, e24668 (2011).
30. Angus-Hill, M.L., Elbert, K.M., Hidalgo, J. & Capecchi, M.R. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc. Natl. Acad. Sci. USA 108, 4914-4919 (2011).
31. Behrens, J. et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280, 596-599 (1998).
32. Yu, H. et al. Twist2 is a valuable prognostic biomarker for colorectal cancer. World J. Gastroenterol. 19, 2404-2411 (2013).
33. Xiong, H. et al. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10, 287-297 (2008).
34. Forcet, C. et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc. Natl. Acad. Sci. USA 98, 3416-3421 (2001).
35. Aylon, Y. et al. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700 (2006).
36. Yabuta, N. et al. Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts. Genomics 63, 263-270 (2000).
37. Funato, K., Yamazumi, Y., Oda, T. & Akiyama, T. Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44. Exp. Ther. Med. 2, 457-463 (2011).
38. Chen, H.J. et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat. Biotechnol. 33, 656-660 (2015).
39. Katoh, M. Functional and cancer genomics of ASXL family members. Br. J. Cancer 109, 299-306 (2013).
40. Williams, D.S. et al. Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability. PLoS One 5, e16012 (2010).
41. Henrich, K.O. et al. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells. Cancer Res. 71, 3142-3151 (2011).
42. Kim, M.Y. et al. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization. Gastroenterology 131, 1913-1924 (2006).
43. Roig, A.I. et al. Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology 138, 1012-1021 (2010).
44. Gomes, C.C. et al. Assessment of TP53 mutations in benign and malignant salivary gland neoplasms. PLoS One 7, e41261 (2012).
45. Groden, J. et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589-600 (1991).
46. Lièvre, A. et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res. 66, 3992-3995 (2006).
47. Ruiz-Ponte, C., Vega, A., Carracedo, A. & Barros, F. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Hum. Mutat. 18, 355 (2001).
48. Maston, G.A., Evans, S.K. & Green, M.R. Transcriptional regulatory elements in the human genome. Annu. Rev. Genomics Hum. Genet. 7, 29-59 (2006).
49. Chen, H.J. et al. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J. Clin. Invest. 122, 3184-3196 (2012).